LY2140023

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for LY2140023, covering 2013-08-02 to 2023-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia [Phase 1]

See pricing